Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Opinion in Immunology is Scopus-indexed (Q1, CiteScore 10), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 0952-7915Verify ISSN ↗1879-0372Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: About US$4,410 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 36 / 234 | 84th | Q1 |
| Immunology | 41 / 243 | 83rd | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1988–present, best quartile Q1, CiteScore 10.
Current Opinion in Immunology is Q1 in Immunology and Allergy (rank 36 of 234) and Q1 in Immunology (rank 41 of 243), by CiteScore 2025.
Current Opinion in Immunology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10, which places it in quartile Q1 at the 84th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.010, quartile Q1, with an H-index of 218.
The publisher lists an article processing charge of about US$4,410 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Current Opinion in Immunology is published by Elsevier Ltd. Its print ISSN is 0952-7915 and its online ISSN is 1879-0372.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Opinion in Immunology has an h-index of 248 and a 2-year mean of 4.35 citations per paper (OpenAlex). Its Scopus CiteScore is 10, quartile Q1. On 2-year citations it ranks #48 of 231 Scopus journals in Immunology and Allergy.
Current Opinion in Immunology published 145 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (33%), Italy (13.7%) and Germany (8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.